A risk assessment of disease progression after virus elimination with chronic hepatitis C
10.3969/j.issn.1001-5256.2018.02.001
- VernacularTitle:慢性丙型肝炎清除病毒后疾病进展风险评估
- Author:
Qin WANG
1
;
Bifen LUO
;
Lai WEI
Author Information
1. 北京大学人民医院
- Keywords:
hepatitis C,chronic;
liver cirrhosis;
carcinoma,hepatocellular;
interferon-alpha;
risk factors;
editorial
- From:
Journal of Clinical Hepatology
2018;34(2):227-228
- CountryChina
- Language:Chinese
-
Abstract:
With reference to various clinical studies on interferon-α and pegylated interferon-α around the world,patients with chronic hepatitis C who receive antiviral therapy and achieve the elimination of hepatitis C virus may have significant relief or even reversion of liver fibrosis,as well as reductions in the incidence rates of decompensated liver cirrhosis,related complications,and hepatocellular carcinoma and an increase in survival rate.
